Hancock Whitney’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.3M | Sell |
67,373
-665
| -1% | -$131K | 0.24% | 108 |
|
|
2026
Q1 | $13.3M | Sell |
68,038
-314
| -0.5% | -$61K | 0.23% | 108 |
|
|
2025
Q4 | $11.9M | Buy |
68,352
+679
| +1% | +$124K | 0.21% | 107 |
|
|
2025
Q3 | $12.9M | Buy |
67,673
+567
| +0.8% | +$101K | 0.23% | 99 |
|
|
2025
Q2 | $12.1M | Buy |
67,106
+59,471
| +779% | +$10.3M | 0.23% | 103 |
|
|
2025
Q1 | $1.29M | Sell |
7,635
-143
| -2% | -$23.5K | 0.04% | 270 |
|
|
2024
Q4 | $1.17M | Sell |
7,778
-1,145
| -13% | -$178K | 0.04% | 293 |
|
|
2024
Q3 | $1.39M | Buy |
8,923
+258
| +3% | +$38.5K | 0.04% | 259 |
|
|
2024
Q2 | $1.19M | Buy |
8,665
+1,337
| +18% | +$183K | 0.04% | 270 |
|
|
2024
Q1 | $975K | Sell |
7,328
-54,083
| -88% | -$7.02M | 0.03% | 314 |
|
|
2023
Q4 | $8.47M | Sell |
61,411
-5,301
| -8% | -$697K | 0.31% | 75 |
|
|
2023
Q3 | $8.13M | Sell |
66,712
-274
| -0.4% | -$36.5K | 0.34% | 76 |
|
|
2023
Q2 | $9.42M | Sell |
66,986
-1,917
| -3% | -$264K | 0.37% | 71 |
|
|
2023
Q1 | $9.75M | Buy |
68,903
+263
| +0.4% | +$37.6K | 0.39% | 63 |
|
|
2022
Q4 | $10.7M | Buy |
68,640
+52,691
| +330% | +$7.57M | 0.41% | 62 |
|
|
2022
Q3 | $1.96M | Sell |
15,949
-2,340
| -13% | -$308K | 0.08% | 196 |
|
|
2022
Q2 | $2.43M | Sell |
18,289
-243
| -1% | -$33.1K | 0.1% | 171 |
|
|
2022
Q1 | $2.54M | Sell |
18,532
-1,275
| -6% | -$178K | 0.09% | 186 |
|
|
2021
Q4 | $3.43M | Buy |
19,807
+490
| +3% | +$74.6K | 0.11% | 157 |
|
|
2021
Q3 | $2.81M | Sell |
19,317
-471
| -2% | -$68.9K | 0.1% | 167 |
|
|
2021
Q2 | $2.61M | Buy |
19,788
+3,348
| +20% | +$438K | 0.08% | 208 |
|
|
2021
Q1 | $2.11M | Buy |
+16,440
| New | +$2.03M | 0.07% | 261 |
|
|
2018
Q1 | – | Sell |
-5,245
| Closed | -$517K | – | 567 |
|
|
2017
Q4 | $517K | Sell |
5,245
-9,882
| -65% | -$937K | 0.02% | 432 |
|
|
2017
Q3 | $1.42M | Sell |
15,127
-1,560
| -9% | -$166K | 0.06% | 262 |
|
|
2017
Q2 | $1.85M | Sell |
16,687
-696
| -4% | -$73.6K | 0.08% | 215 |
|
|
2017
Q1 | $1.71M | Buy |
17,383
+6,211
| +56% | +$592K | 0.07% | 223 |
|
|
2016
Q4 | $1.03M | Buy |
11,172
+60
| +0.5% | +$5.17K | 0.04% | 345 |
|
|
2016
Q3 | $940K | Buy |
+11,112
| New | +$933K | 0.04% | 344 |
|
|
2016
Q1 | – | Sell |
-10,636
| Closed | -$757K | – | 530 |
|
|
2015
Q4 | $757K | Buy |
10,636
+580
| +6% | +$39K | 0.03% | 375 |
|
|
2015
Q3 | $618K | Sell |
10,056
-54,217
| -84% | -$3.79M | 0.03% | 406 |
|
|
2015
Q2 | $4.94M | Hold |
64,273
| – | – | 0.19% | 173 |
|
|
2015
Q1 | $4.94M | Buy |
+64,273
| New | +$4.6M | 0.19% | 173 |
|
|
2013
Q3 | – | Sell |
-9,064
| Closed | -$550K | – | 499 |
|
|
2013
Q2 | $550K | Buy |
+9,064
| New | +$540K | 0.03% | 304 |
|
Other funds holding DGX
EIG
Hancock Whitney's DGX Position: Q2 2026 in Review
Hancock Whitney reduced its Quest Diagnostics (DGX) stake by 0.98% in Q2 2026, selling an estimated $131K and leaving 67,373 shares worth $14.3M. The position accounts for 0.24% of the portfolio, ranked #108.
Hancock Whitney first reported a position in DGX in Q2 2013 and has held it in 33 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Hancock Whitney held 67,373 shares of Quest Diagnostics worth $14.3M as of Q2 2026.
- Hancock Whitney sold 665 Quest Diagnostics shares in Q2 2026, an estimated $131K.
- Quest Diagnostics made up 0.24% of Hancock Whitney's portfolio in Q2 2026, its #108 holding.
- Hancock Whitney first reported a position in Quest Diagnostics in Q2 2013 and has held it in 33 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.